Aldosterone, Urine
Malaria/Babesia Blood Smear
Amoebic Serology
Hepatitis E Virus (HEV) RNA, Molecular, Quantitative
Lead/Creatinine Ratio, Random, Urine
Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Testosterone, Free
Cancer Antigen (CA) 19-9, Peritoneal Fluid
Human Immunodeficiency Virus 1 (HIV-1) RNA, Qualitative or Quantitative
D-Lactate, Urine
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
ICD10
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now